282 related articles for article (PubMed ID: 19188694)
1. Telomerase: cellular immortalization and neoplastic transformation. Multiple functions of a multifaceted complex.
Belgiovine C; Chiodi I; Mondello C
Cytogenet Genome Res; 2008; 122(3-4):255-62. PubMed ID: 19188694
[TBL] [Abstract][Full Text] [Related]
2. Telomeres and telomerase in leukaemia and lymphoma.
Davison GM
Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
[TBL] [Abstract][Full Text] [Related]
3. Analysis of telomerase activity and telomere function in cancer.
Gordon KE; Parkinson EK
Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
[TBL] [Abstract][Full Text] [Related]
4. Telomere lengthening in telomerase-negative cells: the ends are coming together.
Scheel C; Poremba C
Virchows Arch; 2002 Jun; 440(6):573-82. PubMed ID: 12070595
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
[TBL] [Abstract][Full Text] [Related]
6. Chromosome end-to-end associations and telomerase activity during cancer progression in human cells after treatment with alpha-particles simulating radon progeny.
Pandita TK; Hall EJ; Hei TK; Piatyszek MA; Wright WE; Piao CQ; Pandita RK; Willey JC; Geard CR; Kastan MB; Shay JW
Oncogene; 1996 Oct; 13(7):1423-30. PubMed ID: 8875980
[TBL] [Abstract][Full Text] [Related]
7. The roles of telomeres and telomerase in cellular immortalization and the development of cancer.
Klingelhutz AJ
Anticancer Res; 1999; 19(6A):4823-30. PubMed ID: 10697595
[TBL] [Abstract][Full Text] [Related]
8. Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization.
Di Donna S; Mamchaoui K; Cooper RN; Seigneurin-Venin S; Tremblay J; Butler-Browne GS; Mouly V
Mol Cancer Res; 2003 Jul; 1(9):643-53. PubMed ID: 12861050
[TBL] [Abstract][Full Text] [Related]
9. Genetic changes associated with immortalization. A review.
Duncan EL; Reddel RR
Biochemistry (Mosc); 1997 Nov; 62(11):1263-74. PubMed ID: 9467850
[TBL] [Abstract][Full Text] [Related]
10. Telomerase and cancer.
Harley CB; Kim NW
Important Adv Oncol; 1996; ():57-67. PubMed ID: 8791128
[TBL] [Abstract][Full Text] [Related]
11. Telomere maintenance in tumour cells.
Bacchetti S
Cancer Surv; 1996; 28():197-216. PubMed ID: 8977036
[TBL] [Abstract][Full Text] [Related]
12. Telomere instability and cancer.
Londoño-Vallejo JA
Biochimie; 2008 Jan; 90(1):73-82. PubMed ID: 17728038
[TBL] [Abstract][Full Text] [Related]
13. Telomerase is not an oncogene.
Harley CB
Oncogene; 2002 Jan; 21(4):494-502. PubMed ID: 11850774
[TBL] [Abstract][Full Text] [Related]
14. The relationship between telomerase activity and proliferation in cutaneous melanoma.
Zamolo G; Coklo M; Bosnar A; Batinac T
Med Hypotheses; 2007; 68(1):125-7. PubMed ID: 16891062
[TBL] [Abstract][Full Text] [Related]
15. [The opposite roles of telomerase during initiation and progression of cancers].
Brunori M; Gilson E
J Soc Biol; 2004; 198(2):105-11. PubMed ID: 15368958
[TBL] [Abstract][Full Text] [Related]
16. Multiple mechanisms of telomere maintenance exist in liposarcomas.
Johnson JE; Varkonyi RJ; Schwalm J; Cragle R; Klein-Szanto A; Patchefsky A; Cukierman E; von Mehren M; Broccoli D
Clin Cancer Res; 2005 Aug; 11(15):5347-55. PubMed ID: 16061847
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
18. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells.
Nonet GH; Stampfer MR; Chin K; Gray JW; Collins CC; Yaswen P
Cancer Res; 2001 Feb; 61(4):1250-4. PubMed ID: 11245413
[TBL] [Abstract][Full Text] [Related]
19. Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells.
Wen VW; Wu K; Baksh S; Hinshelwood RA; Lock RB; Clark SJ; Moore MA; Mackenzie KL
Cancer Res; 2006 Nov; 66(22):10691-700. PubMed ID: 17108106
[TBL] [Abstract][Full Text] [Related]
20. Telomerase and telomere stability: a new class of tumor suppressor?
Elmore LW; Holt SE
Mol Carcinog; 2000 May; 28(1):1-4. PubMed ID: 10820482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
